Emerging linezolid-resistant Enterococcus faecalis and Enterococcus faecium isolated from two Austrian patients in the same intensive care unit
Of two patients in the same intensive care unit who were treated with linezolid, one yielded linezolid-resistant Enterococcus faecalis, whereas the other yielded linezolid-resistant Enterococcus faecium. In each case, molecular typing indicated that the resistant isolates were related to linezolid-s...
Gespeichert in:
Veröffentlicht in: | European journal of clinical microbiology & infectious diseases 2002-10, Vol.21 (10), p.751-754 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 754 |
---|---|
container_issue | 10 |
container_start_page | 751 |
container_title | European journal of clinical microbiology & infectious diseases |
container_volume | 21 |
creator | JOHNSON, A. P TYSALL, L STOCKDALE, M. W WOODFORD, N KAUFMANN, M. E WARNER, M LIVERMORE, D. M ASBOTH, F ALLERBERGER, F. J |
description | Of two patients in the same intensive care unit who were treated with linezolid, one yielded linezolid-resistant Enterococcus faecalis, whereas the other yielded linezolid-resistant Enterococcus faecium. In each case, molecular typing indicated that the resistant isolates were related to linezolid-susceptible isolates from the same patient, but differed from them by the same G2576U ribosomal RNA mutation. This is the first clinical case report of emerging resistance to linezolid among Enterococcus faecalis and also the first report of resistance involving vancomycin-susceptible rather than vancomycin-resistant enterococci. The linezolid-resistant isolates showed cross-resistance to the experimental oxazolidinone AZD2563, suggesting that oxazolidinone resistance might be a class effect. |
doi_str_mv | 10.1007/s10096-002-0807-0 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_899166265</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>899166265</sourcerecordid><originalsourceid>FETCH-LOGICAL-c452t-190b56e9c2ce2f9c268e06022544e3e735ff83a29b0e4dfc41b01db1c1353bf73</originalsourceid><addsrcrecordid>eNp9kcuKFTEQhoMozjj6AG4kCOqqtXLvLIfheIEBN7pu0unqMUN3-phKO-hL-Mr24RwYUHBTVZDv_yF8jD0X8FYAuHe0TW8bANlAC66BB-xcaGUarZx6yM7BK914J9UZe0J0C1umde4xOxNSC6OdPWe_dzOWm5Rv-JQy_lqmNDQFKVENufJdrliWuMS4Eh8DxjAl4iEP_76kdeaJlilUHPhYlpnXu4VfrlRLCpnvQ02YK_GUef2GnMKM210xU_qBPIaCfM2pPmWPxjARPjvtC_b1_e7L1cfm-vOHT1eX103URtZGeOiNRR9lRDluy7YIFqQ0WqNCp8w4tipI3wPqYYxa9CCGXkShjOpHpy7Ym2PvvizfV6TazYkiTlPIuKzUtd4La6U1G_n6v6STVoNuD5Uv_wJvl7Xk7Rdd6wRIYwA2SByhWBaigmO3L2kO5WcnoDtI7Y5Su01qd5DaHTIvTsVrP-NwnzhZ3IBXJyDQpmgsIcdE95wGYby36g9YMqvy</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>871025500</pqid></control><display><type>article</type><title>Emerging linezolid-resistant Enterococcus faecalis and Enterococcus faecium isolated from two Austrian patients in the same intensive care unit</title><source>MEDLINE</source><source>SpringerNature Complete Journals</source><creator>JOHNSON, A. P ; TYSALL, L ; STOCKDALE, M. W ; WOODFORD, N ; KAUFMANN, M. E ; WARNER, M ; LIVERMORE, D. M ; ASBOTH, F ; ALLERBERGER, F. J</creator><creatorcontrib>JOHNSON, A. P ; TYSALL, L ; STOCKDALE, M. W ; WOODFORD, N ; KAUFMANN, M. E ; WARNER, M ; LIVERMORE, D. M ; ASBOTH, F ; ALLERBERGER, F. J</creatorcontrib><description>Of two patients in the same intensive care unit who were treated with linezolid, one yielded linezolid-resistant Enterococcus faecalis, whereas the other yielded linezolid-resistant Enterococcus faecium. In each case, molecular typing indicated that the resistant isolates were related to linezolid-susceptible isolates from the same patient, but differed from them by the same G2576U ribosomal RNA mutation. This is the first clinical case report of emerging resistance to linezolid among Enterococcus faecalis and also the first report of resistance involving vancomycin-susceptible rather than vancomycin-resistant enterococci. The linezolid-resistant isolates showed cross-resistance to the experimental oxazolidinone AZD2563, suggesting that oxazolidinone resistance might be a class effect.</description><identifier>ISSN: 0934-9723</identifier><identifier>EISSN: 1435-4373</identifier><identifier>DOI: 10.1007/s10096-002-0807-0</identifier><identifier>PMID: 12415476</identifier><language>eng</language><publisher>Berlin: Springer</publisher><subject>Acetamides - pharmacology ; Aged ; Anti-Bacterial Agents - pharmacology ; Antibacterial agents ; Antibiotic resistance ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Austria ; Base Sequence ; Biological and medical sciences ; Cross Infection - diagnosis ; Cross Infection - microbiology ; DNA, Bacterial ; Drug Resistance, Microbial ; Enterococcus faecalis ; Enterococcus faecalis - drug effects ; Enterococcus faecalis - isolation & purification ; Enterococcus faecium ; Enterococcus faecium - drug effects ; Enterococcus faecium - isolation & purification ; Gram-Positive Bacterial Infections - diagnosis ; Humans ; Intensive Care Units ; Linezolid ; Male ; Medical sciences ; Microbial Sensitivity Tests ; Middle Aged ; Molecular Sequence Data ; Oxazolidinones - pharmacology ; Pharmacology. Drug treatments ; Polymerase Chain Reaction ; Sensitivity and Specificity</subject><ispartof>European journal of clinical microbiology & infectious diseases, 2002-10, Vol.21 (10), p.751-754</ispartof><rights>2003 INIST-CNRS</rights><rights>Springer-Verlag 2002</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c452t-190b56e9c2ce2f9c268e06022544e3e735ff83a29b0e4dfc41b01db1c1353bf73</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=14015996$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12415476$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>JOHNSON, A. P</creatorcontrib><creatorcontrib>TYSALL, L</creatorcontrib><creatorcontrib>STOCKDALE, M. W</creatorcontrib><creatorcontrib>WOODFORD, N</creatorcontrib><creatorcontrib>KAUFMANN, M. E</creatorcontrib><creatorcontrib>WARNER, M</creatorcontrib><creatorcontrib>LIVERMORE, D. M</creatorcontrib><creatorcontrib>ASBOTH, F</creatorcontrib><creatorcontrib>ALLERBERGER, F. J</creatorcontrib><title>Emerging linezolid-resistant Enterococcus faecalis and Enterococcus faecium isolated from two Austrian patients in the same intensive care unit</title><title>European journal of clinical microbiology & infectious diseases</title><addtitle>Eur J Clin Microbiol Infect Dis</addtitle><description>Of two patients in the same intensive care unit who were treated with linezolid, one yielded linezolid-resistant Enterococcus faecalis, whereas the other yielded linezolid-resistant Enterococcus faecium. In each case, molecular typing indicated that the resistant isolates were related to linezolid-susceptible isolates from the same patient, but differed from them by the same G2576U ribosomal RNA mutation. This is the first clinical case report of emerging resistance to linezolid among Enterococcus faecalis and also the first report of resistance involving vancomycin-susceptible rather than vancomycin-resistant enterococci. The linezolid-resistant isolates showed cross-resistance to the experimental oxazolidinone AZD2563, suggesting that oxazolidinone resistance might be a class effect.</description><subject>Acetamides - pharmacology</subject><subject>Aged</subject><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Antibacterial agents</subject><subject>Antibiotic resistance</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Austria</subject><subject>Base Sequence</subject><subject>Biological and medical sciences</subject><subject>Cross Infection - diagnosis</subject><subject>Cross Infection - microbiology</subject><subject>DNA, Bacterial</subject><subject>Drug Resistance, Microbial</subject><subject>Enterococcus faecalis</subject><subject>Enterococcus faecalis - drug effects</subject><subject>Enterococcus faecalis - isolation & purification</subject><subject>Enterococcus faecium</subject><subject>Enterococcus faecium - drug effects</subject><subject>Enterococcus faecium - isolation & purification</subject><subject>Gram-Positive Bacterial Infections - diagnosis</subject><subject>Humans</subject><subject>Intensive Care Units</subject><subject>Linezolid</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Microbial Sensitivity Tests</subject><subject>Middle Aged</subject><subject>Molecular Sequence Data</subject><subject>Oxazolidinones - pharmacology</subject><subject>Pharmacology. Drug treatments</subject><subject>Polymerase Chain Reaction</subject><subject>Sensitivity and Specificity</subject><issn>0934-9723</issn><issn>1435-4373</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp9kcuKFTEQhoMozjj6AG4kCOqqtXLvLIfheIEBN7pu0unqMUN3-phKO-hL-Mr24RwYUHBTVZDv_yF8jD0X8FYAuHe0TW8bANlAC66BB-xcaGUarZx6yM7BK914J9UZe0J0C1umde4xOxNSC6OdPWe_dzOWm5Rv-JQy_lqmNDQFKVENufJdrliWuMS4Eh8DxjAl4iEP_76kdeaJlilUHPhYlpnXu4VfrlRLCpnvQ02YK_GUef2GnMKM210xU_qBPIaCfM2pPmWPxjARPjvtC_b1_e7L1cfm-vOHT1eX103URtZGeOiNRR9lRDluy7YIFqQ0WqNCp8w4tipI3wPqYYxa9CCGXkShjOpHpy7Ym2PvvizfV6TazYkiTlPIuKzUtd4La6U1G_n6v6STVoNuD5Uv_wJvl7Xk7Rdd6wRIYwA2SByhWBaigmO3L2kO5WcnoDtI7Y5Su01qd5DaHTIvTsVrP-NwnzhZ3IBXJyDQpmgsIcdE95wGYby36g9YMqvy</recordid><startdate>20021001</startdate><enddate>20021001</enddate><creator>JOHNSON, A. P</creator><creator>TYSALL, L</creator><creator>STOCKDALE, M. W</creator><creator>WOODFORD, N</creator><creator>KAUFMANN, M. E</creator><creator>WARNER, M</creator><creator>LIVERMORE, D. M</creator><creator>ASBOTH, F</creator><creator>ALLERBERGER, F. J</creator><general>Springer</general><general>Springer Nature B.V</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope></search><sort><creationdate>20021001</creationdate><title>Emerging linezolid-resistant Enterococcus faecalis and Enterococcus faecium isolated from two Austrian patients in the same intensive care unit</title><author>JOHNSON, A. P ; TYSALL, L ; STOCKDALE, M. W ; WOODFORD, N ; KAUFMANN, M. E ; WARNER, M ; LIVERMORE, D. M ; ASBOTH, F ; ALLERBERGER, F. J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c452t-190b56e9c2ce2f9c268e06022544e3e735ff83a29b0e4dfc41b01db1c1353bf73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Acetamides - pharmacology</topic><topic>Aged</topic><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Antibacterial agents</topic><topic>Antibiotic resistance</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Austria</topic><topic>Base Sequence</topic><topic>Biological and medical sciences</topic><topic>Cross Infection - diagnosis</topic><topic>Cross Infection - microbiology</topic><topic>DNA, Bacterial</topic><topic>Drug Resistance, Microbial</topic><topic>Enterococcus faecalis</topic><topic>Enterococcus faecalis - drug effects</topic><topic>Enterococcus faecalis - isolation & purification</topic><topic>Enterococcus faecium</topic><topic>Enterococcus faecium - drug effects</topic><topic>Enterococcus faecium - isolation & purification</topic><topic>Gram-Positive Bacterial Infections - diagnosis</topic><topic>Humans</topic><topic>Intensive Care Units</topic><topic>Linezolid</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Microbial Sensitivity Tests</topic><topic>Middle Aged</topic><topic>Molecular Sequence Data</topic><topic>Oxazolidinones - pharmacology</topic><topic>Pharmacology. Drug treatments</topic><topic>Polymerase Chain Reaction</topic><topic>Sensitivity and Specificity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>JOHNSON, A. P</creatorcontrib><creatorcontrib>TYSALL, L</creatorcontrib><creatorcontrib>STOCKDALE, M. W</creatorcontrib><creatorcontrib>WOODFORD, N</creatorcontrib><creatorcontrib>KAUFMANN, M. E</creatorcontrib><creatorcontrib>WARNER, M</creatorcontrib><creatorcontrib>LIVERMORE, D. M</creatorcontrib><creatorcontrib>ASBOTH, F</creatorcontrib><creatorcontrib>ALLERBERGER, F. J</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of clinical microbiology & infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>JOHNSON, A. P</au><au>TYSALL, L</au><au>STOCKDALE, M. W</au><au>WOODFORD, N</au><au>KAUFMANN, M. E</au><au>WARNER, M</au><au>LIVERMORE, D. M</au><au>ASBOTH, F</au><au>ALLERBERGER, F. J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Emerging linezolid-resistant Enterococcus faecalis and Enterococcus faecium isolated from two Austrian patients in the same intensive care unit</atitle><jtitle>European journal of clinical microbiology & infectious diseases</jtitle><addtitle>Eur J Clin Microbiol Infect Dis</addtitle><date>2002-10-01</date><risdate>2002</risdate><volume>21</volume><issue>10</issue><spage>751</spage><epage>754</epage><pages>751-754</pages><issn>0934-9723</issn><eissn>1435-4373</eissn><abstract>Of two patients in the same intensive care unit who were treated with linezolid, one yielded linezolid-resistant Enterococcus faecalis, whereas the other yielded linezolid-resistant Enterococcus faecium. In each case, molecular typing indicated that the resistant isolates were related to linezolid-susceptible isolates from the same patient, but differed from them by the same G2576U ribosomal RNA mutation. This is the first clinical case report of emerging resistance to linezolid among Enterococcus faecalis and also the first report of resistance involving vancomycin-susceptible rather than vancomycin-resistant enterococci. The linezolid-resistant isolates showed cross-resistance to the experimental oxazolidinone AZD2563, suggesting that oxazolidinone resistance might be a class effect.</abstract><cop>Berlin</cop><pub>Springer</pub><pmid>12415476</pmid><doi>10.1007/s10096-002-0807-0</doi><tpages>4</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0934-9723 |
ispartof | European journal of clinical microbiology & infectious diseases, 2002-10, Vol.21 (10), p.751-754 |
issn | 0934-9723 1435-4373 |
language | eng |
recordid | cdi_proquest_miscellaneous_899166265 |
source | MEDLINE; SpringerNature Complete Journals |
subjects | Acetamides - pharmacology Aged Anti-Bacterial Agents - pharmacology Antibacterial agents Antibiotic resistance Antibiotics. Antiinfectious agents. Antiparasitic agents Austria Base Sequence Biological and medical sciences Cross Infection - diagnosis Cross Infection - microbiology DNA, Bacterial Drug Resistance, Microbial Enterococcus faecalis Enterococcus faecalis - drug effects Enterococcus faecalis - isolation & purification Enterococcus faecium Enterococcus faecium - drug effects Enterococcus faecium - isolation & purification Gram-Positive Bacterial Infections - diagnosis Humans Intensive Care Units Linezolid Male Medical sciences Microbial Sensitivity Tests Middle Aged Molecular Sequence Data Oxazolidinones - pharmacology Pharmacology. Drug treatments Polymerase Chain Reaction Sensitivity and Specificity |
title | Emerging linezolid-resistant Enterococcus faecalis and Enterococcus faecium isolated from two Austrian patients in the same intensive care unit |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T00%3A42%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Emerging%20linezolid-resistant%20Enterococcus%20faecalis%20and%20Enterococcus%20faecium%20isolated%20from%20two%20Austrian%20patients%20in%20the%20same%20intensive%20care%20unit&rft.jtitle=European%20journal%20of%20clinical%20microbiology%20&%20infectious%20diseases&rft.au=JOHNSON,%20A.%20P&rft.date=2002-10-01&rft.volume=21&rft.issue=10&rft.spage=751&rft.epage=754&rft.pages=751-754&rft.issn=0934-9723&rft.eissn=1435-4373&rft_id=info:doi/10.1007/s10096-002-0807-0&rft_dat=%3Cproquest_cross%3E899166265%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=871025500&rft_id=info:pmid/12415476&rfr_iscdi=true |